CTAD Boston 2-4, 2017
Alzheimer’s disease is one of the most important health challenges facing aging populations worldwide. The development of the next generation of Alzheimer’s disease drugs is becoming essential to face up to this challenge.
March 15 online submission opens deadline to submit the abstract June 8
September 1 online submission opens deadline to submit the abstract September 15
Online registrations will open on April 15